3.
36例突变患者的单因素分析
Univariate analysis of PFS in 36 EGFR mutation patients
| Variables | PFS | 95%CI | P |
| PFS: progression-free survival. | |||
| Gender | 0.39 | ||
| Male | 8.7 | 6.9-10.5 | |
| Female | 9.5 | 7.6-11.4 | |
| Performance status | 0.054 | ||
| 0-1 | 10.5 | 8.8-12.2 | |
| 2 | 7.0 | 5.8-8.2 | |
| Age (year) | 0.21 | ||
| < 65 | 8.5 | 7.5-10.5 | |
| ≥65 | 10.8 | 9.6-12.0 | |
| Smoking characteristics | 0.75 | ||
| Yes | 8.7 | 5.6-11.8 | |
| No | 9.5 | 7.9-11.1 | |
| Brain metastasis | 0.69 | ||
| Yes | 8.7 | 7.0-9.9 | |
| No | 10.0 | 6.6-13.8 | |
| Stage | 0.22 | ||
| Ⅲb | 7, 4 | 8.0-11.0 | |
| Ⅳ | 9.5 | - | |
| Prior chemotherapy | 0.41 | ||
| 0 | 9.5 | 7.9-11.0 | |
| ≥1 | 8.5 | 6.5-10.5 | |
| Mutation type | 0.35 | ||
| Exon 19 | 11.0 | 8.0-13.1 | |
| Other | 8.5 | 6.9-11.0 | |